Methamphetamine causes persistent immune dysregulation: A cross-species, translational report

Neurotoxicity Research

Volumn 20, Issue 1, 2011, Pages 59-68

  Loftis, Jennifer M ^a,c   Choi, Dongseok ^b   Hoffman, William ^a,c   Huckans, Marilyn S ^a,c  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Adhesion molecules; Chemokines; Cytokines; Methamphetamine; Neuroinflammation; Substance abuse

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; METHAMPHETAMINE; MONOCYTE CHEMOTACTIC PROTEIN 1; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CENTRAL NERVOUS SYSTEM DISEASE; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG DEPENDENCE; FEMALE; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; IMMUNE DYSREGULATION; IMMUNOPATHOGENESIS; MALE; MOUSE; NEUROPATHOLOGY; NEUROPSYCHOLOGICAL TEST; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REMISSION; TISSUE SPECIFICITY; TRANSLATIONAL RESEARCH;

ADULT; AMPHETAMINE-RELATED DISORDERS; ANIMALS; BRAIN; CHEMOKINE CCL2; CHEMOKINES; COGNITION DISORDERS; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNE SYSTEM DISEASES; IMMUNOLOGIC FACTORS; INTERCELLULAR ADHESION MOLECULE-1; MALE; METHAMPHETAMINE; MICE; MICE, INBRED C57BL; NEUROPSYCHOLOGICAL TESTS; RANDOM ALLOCATION;

MUS;

EID: 79958133175     PISSN: 10298428     EISSN: 14763524     Source Type: Journal    
DOI: 10.1007/s12640-010-9223-x     Document Type: Article

References (68)

1. Adler MW, Rogers TJ (2005) Are chemokines the third major system in the brain? J Leukoc Biol 78(6):1204-1209
2. American Psychiatric Association (2000) Diagnostic and statistical manual for mental disorders, text revision ed, 4th edn. American Psychiatric Association, Washington, DC
3. Archambault AS, Sim J, McCandless EE et al (2006) Region-specific regulation of inflammation and pathogenesis in experimental autoimmune encephalomyelitis. J Neuroimmunol 181(1-2):122-132 (Pubitemid 44830141)
4. Benamar K, Geller EB, Adler MW (2008) First in vivo evidence for a functional interaction between chemokine and cannabinoid systems in the brain. J Pharmacol Exp Ther 325(2):641-645 (Pubitemid 351574816)
5. Berman S, O'Neill J, Fears S et al (2008) Abuse of amphetamines and structural abnormalities in the brain. Ann N Y Acad Sci 1141:195-220
6. Bowyer JF, Ali S (2006) High doses of methamphetamine that cause disruption of the blood-brain barrier in limbic regions produce extensive neuronal degeneration in mouse hippocampus. Synapse 60:521-532 (Pubitemid 44537085)
7. Butler MP, O'Connor JJ, Moynagh PN (2004) Dissection of tumornecrosis factor-alpha inhibition of long-term potentiation (LTP) reveals a p38 mitogen-activated protein kinase-dependent mechanism which maps to early-but not late-phase LTP. Neuroscience 124(2):319-326 (Pubitemid 38229652)
8. Cadet JL, Krasnova IN, Jayanthi S et al (2007) Neurotoxicity of substituted amphetamines: molecular and cellular mechanisms. Neurotox Res 11(3-4):183-202
9. Cass WA (1997) Decreases in evoked overflow of dopamine in rat striatum after neurotoxic doses of methamphetamine. J Pharmacol Exp Ther 280:105-113
10. Cherner M, Suarez P, Casey C et al (2010) Methamphetamine use parameters do not predict neuropsychological impairment in currently abstinent dependent adults. Drug Alcohol Depend 106(2-3):154-163
11. Cunningham ET, Wada E, Carter DB et al (1992) In situ histochemical localization of type I interleukin-1 receptor messenger RNA in the central nervous system, pituitary, and adrenal gland of the mouse. J Neurosci 12(3):1101-1114
12. Cunningham AJ, Murray CA, O'Neill LA et al (1996) Interleukin-1 beta (IL-1 beta) and tumour necrosis factor (TNF) inhibit longterm potentiation in the rat dentate gyrus in vitro. Neurosci Lett 203(1):17-20
13. de Araujo EG, da Silva GM, Dos Santos AA (2009) Neuronal cell survival: the role of interleukins. Ann N Y Acad Sci 1153:57-64
14. Eisch AJ, Gaffney M, Weihmuller FB et al (1992) Striatal subregions are differentially vulnerable to the neurotoxic effects of methamphetamine. Brain Res 598:321-326 (Pubitemid 23013078)
15. Figueiredo-Braga M, Mota-Garcia F, O'Connor JE et al (2009) Cytokines and anxiety in systemic lupus erythematosus (SLE) patients not receiving antidepressant medication: a little-explored frontier and some of its brief history. Ann N Y Acad Sci 1173:286-291
16. Fitting S, Zou S, Chen W et al (2010) Regional heterogeneity and diversity in cytokine and chemokine production by astroglia: differential responses to HIV-1 Tat, gp120, and morphine revealed by multiplex analysis. J Proteome Res 9(4):1795-1804
17. Fukui K, Kariyama H, Kashiba A et al (1986) Further confirmation of heterogeneity of the rat striatum: differentmosaic patterns of dopamine fibers after administration of methamphetamineor reserpine. Brain Res 382:81-86 (Pubitemid 16018032)
18. Gonçalves J, Baptista S, Martins T et al (2010) Methamphetamine-induced neuroinflammation and neuronal dysfunction in the mice hippocampus: preventive effect of indomethacin. Eur J Neurosci 31(2):315-326
19. Harvey DC, Lacan G, Melegan WP (2000) Regional heterogeneityof dopaminergic deficits in vervet monkey striatum and substantia nigra after methamphetamine exposure. Exp Brain Res 133:349-358 (Pubitemid 30459542)
20. Haughey HM, Brown JM, Wilkins DG et al (2000) Differential effects of methamphetamine on Na(+)/Cl(-))-dependent transporters. Brain Res 863:59-65 (Pubitemid 30201584)
21. He J, Crews FT (2008) Increased MCP-1 and microglia in various regions of the human alcoholic brain. Exp Neurol 210(2):349-358
22. Hilsabeck RC, Anstead GM, Webb AL et al (2010) Cognitive efficiency is associated with endogenous cytokine levels in patients with chronic hepatitis C. J Neuroimmunol 221(1-2):53-61
23. Hirata H, Ladenheim B, Carlson E et al (1996) Autoradiographic evidence for methamphetamine-induced striatal dopaminergic loss in mouse brain: attenuation in CuZn-superoxide dismutase transgenic mice. Brain Res 714:95-103 (Pubitemid 26122275)
24. Hoffman WD, Schwartz DL, Huckans MS et al (2008) Cortical activation during delay discounting in abstinent methamphetamine dependent individuals. Psychopharmacology 201:183-193
25. In SW, Son EW, Rhee DK et al (2005) Methamphetamine administration produces immunomodulation in mice. J Toxicol Environ Health A 68(23-24):2133-2145
26. Ito Y, Takuma K, Mizoguchi H et al (2007) A novel azaindolizinone derivative ZSET1446 (spiro[imidazo[1,2-a]pyridine-3,2-indan]-2(3H)-one) improves methamphetamine-induced impairment of recognition memory in mice by activating extracellular signal-regulated kinase 1/2. J Pharmacol Exp Ther 320(2):819-827 (Pubitemid 46147964)
27. Kamei H, Nagai T, Nakano H et al (2006) Repeated methamphetamine treatment impairs recognition memory. Biol Psychiatry 59(1):75-84
28. Kelder W, McArthur JC, Nance-Sproson T et al (1998) Betachemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia. Ann Neurol 44(5):831-835 (Pubitemid 28516058)
29. Khairova RA, Machado-Vieira R, Du J et al (2009) A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder. Int J Neuropsychopharmacol 12(4):561-578
30. Kipp M, Norkute A, Johann S et al (2008) Brain-region-specific astroglial responses in vitro after LPS exposure. J Mol Neurosci 35(2):235-243
31. Kiyatkin EA, Brown PL, Sharma HS (2007) Brain edema and breakdown of the blood-brain barrier during methamphetamine intoxication: critical role of brain hyperthermia. Eur J Neurosci 26(5):1242-1253 (Pubitemid 47346759)
32. Kuhn DM, Francescutti-Verbeem DM, Thomas DM (2006) Dopamine quinones activate microglia and induce a neurotoxic gene expression profile: relationship to methamphetamine-induced nerve ending damage. Ann N Y Acad Sci 1074:31-41 (Pubitemid 44532808)
33. Letendre SL, Cherner M, Ellis RJ et al (2005) The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease. AIDS Suppl 3:S72-S78
34. Loftis JM, Huckans M (2010) Methamphetamine impairs cognitive and cerebral function and alters the expression of neuroimmune factors in mice and humans. Clin Transl Sci 3(2):S8-S55, A-235
35. Loftis JM, Huckans M, Ruimy S et al (2008) Depressive symptoms in patients with chronic hepatitis C are correlated with elevated plasma levels of interleukin-1β and tumor necrosis factor-α. Neurosci Lett 430:264-268
36. Loftis JM, Huckans MS, Williams A (2009) Methamphetamine administration causes increased neuroinflammation accompanied by peripheral immunosupression in mice. Brain Behav Immun 23(Suppl. 2):S46-S47
37. Loftis JM, Huckans M, Morasco BJ (2010) Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies. Neurobiol Dis 37(3):519-533
38. London ED, Simon SL, Berman SM et al (2004) Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Arch Gen Psychiatry 61:73-84 (Pubitemid 38044643)
39. Lu P, Mamiya T, Lu L et al (2009) Silibinin attenuates cognitive deficits and decreases of dopamine and serotonin induced by repeated methamphetamine treatment. Behav Brain Res 207(2):387-393
40. Martinez LR, Mihu MR, Gácser A et al (2009) Methamphetamine enhances histoplasmosis by immunosuppression of the host. J Infect Dis 200(1):131-141
41. McAfoose J, Baune BT (2009) Evidence for a cytokine model of cognitive function. Neurosci Biobehav Rev 33(3):355-366
42. Meyers CA, Albitar M, Estey E (2005) Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Cancer 104(4):788-793 (Pubitemid 41113679)
43. Miyazaki I, Asanuma M (2009) Approaches to prevent dopamine quinone-induced neurotoxicity. Neurochem Res 34(4):698-706
44. Mizoguchi H, Takuma K, Fukakusa A et al (2008) Improvement by minocycline of methamphetamine-induced impairment of recognition memory in mice. Psychopharmacology 196:233-241
45. Narita M, Suzuki M, Kuzumaki N et al (2008) Implication of activated astrocytes in the development of drug dependence: differences between methamphetamine and morphine. Ann N Y Acad Sci 1141:96-104
46. Numachi Y, Ohara A, Yamashita M et al (2007) Methamphetamine-induced hyperthermia and lethal toxicity: role of the dopamine and serotonin transporters. Eur J Pharmacol 572(2-3):120-128 (Pubitemid 47429639)
47. Parnet P, Amindari S, Wu C et al (1994) Expression of type I and type II interleukin-1 receptors in mouse brain. Brain Res Mol Brain Res 27(1):63-70 (Pubitemid 24324090)
48. Pucak ML, Carroll KA, Kerr DA et al (2007) Neuropsychiatric manifestations of depression in multiple sclerosis: neuroinflammatory, neuroendocrine, and neurotrophic mechanisms in the pathogenesis of immune-mediated depression. Dialogues Clin Neurosci 9(2):125-139 (Pubitemid 47075461)
49. Randolph C (1998) Repeatable battery for the assessment of neuropsychological status. Harcourt Assessment, New York
50. Regan-Shaw S, Minakshi N, Nihal A (2007) Dose translation from animal to human studies revisited. FASEB J 22:659-661
51. Saito M, Yamaguchi T, Kawata T et al (2006) Effects of methamphetamine on cortisone concentration, NK cell activity and mitogen response of T-lymphocytes in female cynomolgus monkeys. Exp Anim 55(5):477-481
52. Schöbitz B, de Kloet ER, Sutanto W et al (1993) Cellular localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain. Eur J Neurosci 5(11):1426-1435 (Pubitemid 23325225)
53. Schuster CR, Fischman MW (1975) Amphetamine toxicity: behavioral and neuropathological indexes. Fed Proc 34(9):1845-1851
54. Schwartz DL, Mitchell AD, Lahna DL et al (2010) Global and local morphometric differences in recently abstinent methamphetamine-dependent individuals. Neuroimage 50(4):1392-1401
55. Scott JC, Woods SP, Matt GE et al (2007) Neurocognitive effects of methamphetamine: a critical review and meta-analysis. Neuropsychol Rev 17:275-297 (Pubitemid 47498174)
56. Sekine Y, Ouchi Y, Sugihara G et al (2008) MA causes microglial activation in the brains of human abusers. J Neurosci 28:5756-5761
57. Sevigny JJ, Albert SM, McDermott MP et al (2004) Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia. Neurology 63(11):2084-2090 (Pubitemid 39636256)
58. Swant J, Chirwa S, Stanwood G, Khoshbouei H (2010) Methamphetamine reduces LTP and increases baseline synaptic transmission in the CA1 region of mouse hippocampus. PLoS One 5(6):e11382
59. Thomas DM, Walker PD, Benjamins JA et al (2004) Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation. J Pharmacol Exp Ther 311:1-7 (Pubitemid 39287777)
60. Thompson PM, Hayashi KM, Simon SL et al (2004) Structural abnormalities in the brains of human subjects who use methamphetamine. J Neurosci 24(26):6028-6036 (Pubitemid 38859399)
61. Tocharus J, Khonthun C, Chongthammakun S et al (2010) Melatonin attenuates methamphetamine-induced overexpression of pro-inflammatory cytokines in microglial cell lines. J Pineal Res 48(4):347-352
62. van Exel E, de Craen AJ, Remarque EJ et al (2003) Interaction of atherosclerosis and inflammation in elderly subjects with poor cognitive function. Neurology 61(12):1695-1701 (Pubitemid 38020814)
63. Volkow ND, Chang L, Wang GJ et al (2001) Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry 158:2015-2021 (Pubitemid 33104107)
64. Wechsler D (1997) Wechsler adult intelligence scale, administration and scoring manual, 3rd edn. Psychological Corporation, New York
65. Yamamoto BK, Raudensky J (2008) The role of oxidative stress, metabolic compromise, and inflammation in neuronal injury produced by amphetamine-related drugs of abuse. J Neuroimmune Pharmacol 3:203-217
66. Yamamoto BK, Moszczynska A, Gudelsky GA (2010) Amphetamine toxicities: classical and emerging mechanisms. Ann N Y Acad Sci 1187:101-121
67. Ye L, Peng JS, Wang X et al (2008) Methamphetamine enhances Hepatitis C virus replication in human hepatocytes. J Viral Hepat 15(4):261-270 (Pubitemid 351326907)
68. Yu Q, Zhang E, Walston M et al (2002) Chronic methamphetamine exposure alters immune function in normal and retrovirus-infected mice. Int Immunopharmacol 2:951-962 (Pubitemid 34756386)